Acute management of migraine

Area of Science:

• Neurology
• Pharmacology

Background:

• Migraine is a debilitating neurological disorder characterized by episodic head pain and associated symptoms.
• Effective migraine management requires addressing acute attacks, associated symptoms, and prevention, particularly for young patients with life considerations.

Purpose of the Study:

• To review current migraine treatment strategies, focusing on acute attack management.
• To evaluate the efficacy and tolerability of specific anti-migraine medications, particularly triptans.

Main Methods:

• Review of non-specific and specific anti-migraine drug classes.
• Comparison of step-care and stratified care approaches in migraine treatment.
• Analysis of triptan efficacy, tolerability, and comparison to ergots.

Main Results:

• Non-specific drugs (NSAIDs, anti-emetics) are useful for mild to moderate attacks; specific drugs (triptans, ergots) for moderate to severe attacks.
• Triptans are the most favored acute treatment, with rizatriptan 10 mg, eletriptan 80 mg, and almotriptan 12.5 mg showing high success rates.
• Triptans are generally well-tolerated with short-lived, mild adverse events, and are replacing ergots due to better side-effect profiles and bioavailability.

Conclusions:

• Triptans represent a highly effective and well-tolerated class of acute migraine medications.
• Current treatment strategies favor triptans over ergots for managing moderate to severe migraine attacks.
• Personalized treatment plans considering patient lifestyle are crucial for effective migraine management.